Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib

Leukemia Research - Tập 31 - Trang 1441-1444 - 2007
Baijun Fang1, Yongping Song1, Zhengtao Han1, Xudong Wei1, Quande Lin1, Xiaoxiu Zhu2, Ruyu Yang3, Junzhong Sun4, Guofeng Tian5, Xinjian Liu5, Guoshun Cao2, Yin Shi6, Neng Nie6, Dapeng Li6, Robert Chunhua Zhao6
1Henan Tumor Hospital, Henan Institute of Haematology, Henan Medical School, Henan University, 127 Dongming Road, Zhengzhou 450008, China
2District People's Hospital of Shangqiu, Shangqiu, Henan, China
3Central Hospital, Nanyang, Henan, China
4People's First Hospital of Nanyang, Nanyang, Henan, China
5Xinhua Hospital, Pingdingshan, Henan, China
6Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Leukemia Research

Tập 31

1441-1444

Thông tin tác giả